Teleflex Incorporated $TFX Shares Sold by Mountain Pacific Investment Advisers LLC

Key Points

• Mountain Pacific Investment Advisers LLC reduced its stake in Teleflex Incorporated by 25.3% during Q2, owning 11,448 shares valued at approximately $1.36 million at the end of the quarter.
• Insiders, including Directors Gretchen R. Haggerty and Jaewon Ryu, notably increased their positions by purchasing 2,000 shares combined at an average price between $114.75 and $115.00.
• Teleflex recently reported a quarterly earnings per share (EPS) of $3.73, exceeding estimates and forecasting a FY 2025 EPS of $13.900 to $14.300.

Mountain Pacific Investment Advisers LLC lowered its stake in Teleflex Incorporated (NYSE:TFX - Free Report) by 25.3% during the second quarter, according to its most recent disclosure with the Securities and Exchange Commission (SEC). The fund owned 11,448 shares of the medical technology company's stock after selling 3,879 shares during the quarter. Mountain Pacific Investment Advisers LLC's holdings in Teleflex were worth $1,355,000 at the end of the most recent quarter.

Several other hedge funds also recently bought and sold shares of the stock. Banque Cantonale Vaudoise acquired a new position in shares of Teleflex in the 1st quarter worth approximately $27,000. MassMutual Private Wealth & Trust FSB raised its position in Teleflex by 103.1% in the first quarter. MassMutual Private Wealth & Trust FSB now owns 197 shares of the medical technology company's stock valued at $27,000 after purchasing an additional 100 shares during the period. Costello Asset Management INC acquired a new position in Teleflex during the first quarter worth $28,000. Brooklyn Investment Group boosted its position in shares of Teleflex by 258.6% during the first quarter. Brooklyn Investment Group now owns 208 shares of the medical technology company's stock worth $29,000 after buying an additional 150 shares during the period. Finally, Thurston Springer Miller Herd & Titak Inc. boosted its position in shares of Teleflex by 242.9% during the second quarter. Thurston Springer Miller Herd & Titak Inc. now owns 216 shares of the medical technology company's stock worth $26,000 after buying an additional 153 shares during the period. Hedge funds and other institutional investors own 95.62% of the company's stock.

Insiders Place Their Bets

In related news, Director Gretchen R. Haggerty purchased 500 shares of the company's stock in a transaction on Wednesday, August 6th. The shares were bought at an average cost of $114.75 per share, for a total transaction of $57,375.00. Following the completion of the purchase, the director directly owned 6,305 shares of the company's stock, valued at approximately $723,498.75. This trade represents a 8.61% increase in their position. The purchase was disclosed in a legal filing with the SEC, which can be accessed through this link. Also, Director Jaewon Ryu acquired 1,500 shares of Teleflex stock in a transaction dated Tuesday, August 5th. The shares were bought at an average price of $115.00 per share, with a total value of $172,500.00. Following the transaction, the director directly owned 3,727 shares in the company, valued at approximately $428,605. The trade was a 67.36% increase in their position. The disclosure for this purchase can be found here. In the last quarter, insiders have bought 5,500 shares of company stock worth $633,590. 1.40% of the stock is currently owned by company insiders.

Teleflex Stock Up 1.3%

Shares of NYSE:TFX opened at $123.93 on Thursday. The firm's 50 day moving average price is $122.91 and its 200 day moving average price is $124.96. The stock has a market cap of $5.48 billion, a price-to-earnings ratio of 29.16, a price-to-earnings-growth ratio of 1.71 and a beta of 1.05. Teleflex Incorporated has a fifty-two week low of $108.90 and a fifty-two week high of $245.32. The company has a quick ratio of 1.44, a current ratio of 2.41 and a debt-to-equity ratio of 0.42.

Teleflex (NYSE:TFX - Get Free Report) last posted its quarterly earnings results on Thursday, July 31st. The medical technology company reported $3.73 EPS for the quarter, topping the consensus estimate of $3.36 by $0.37. Teleflex had a net margin of 6.31% and a return on equity of 15.08%. The company had revenue of $780.90 million during the quarter, compared to analysts' expectations of $771.53 million. During the same quarter in the previous year, the business posted $3.42 EPS. The firm's revenue was up 4.2% on a year-over-year basis. Teleflex has set its FY 2025 guidance at 13.900-14.300 EPS. As a group, equities research analysts predict that Teleflex Incorporated will post 13.98 earnings per share for the current fiscal year.

Teleflex Announces Dividend

The firm also recently disclosed a quarterly dividend, which was paid on Monday, September 15th. Stockholders of record on Friday, August 15th were given a dividend of $0.34 per share. This represents a $1.36 annualized dividend and a dividend yield of 1.1%. The ex-dividend date of this dividend was Friday, August 15th. Teleflex's dividend payout ratio is currently 32.00%.

Analyst Ratings Changes

TFX has been the topic of several research analyst reports. Wells Fargo & Company cut their price objective on Teleflex from $137.00 to $131.00 and set an "equal weight" rating on the stock in a report on Friday, August 1st. Mizuho increased their price target on shares of Teleflex from $130.00 to $135.00 and gave the stock a "neutral" rating in a research report on Friday, August 1st. Royal Bank Of Canada lifted their price objective on shares of Teleflex from $130.00 to $135.00 and gave the company a "sector perform" rating in a report on Friday, August 1st. Finally, Wall Street Zen downgraded shares of Teleflex from a "strong-buy" rating to a "buy" rating in a research note on Monday, September 15th. One equities research analyst has rated the stock with a Buy rating, eight have issued a Hold rating and one has given a Sell rating to the stock. According to data from MarketBeat.com, Teleflex has an average rating of "Hold" and a consensus target price of $141.57.

About Teleflex

Teleflex Incorporated designs, develops, manufactures, and supplies single-use medical devices for common diagnostic and therapeutic procedures in critical care and surgical applications worldwide. The company provides vascular access products that comprise Arrow branded catheters, catheter navigation and tip positioning systems, and intraosseous access systems for the administration of intravenous therapies, the measurement of blood pressure, and the withdrawal of blood samples through a single puncture site.

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.